Old names:
Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by UROQUEST MEDICAL CORP
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000891618-99-005828 ( Act) Size: 4 KB |
Dec-27-1999 | 99780900 |
DEFM14A | Document | Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0000891618-99-005495 ( Act) Size: 528 KB |
Dec-02-1999 | 99767951 |
10-Q/A | Document | Amendment to Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-99-005282 ( Act) Size: 80 KB |
Nov-16-1999 | 99758970 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-99-005253 ( Act) Size: 77 KB |
Nov-15-1999 | 99756509 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-99-003798 ( Act) Size: 75 KB |
Aug-16-1999 | 99690278 |
8-K | Document | Current report filing Acc-no: 0000891618-99-002705 ( Act) Size: 179 KB |
Jun-15-1999 | 99646692 |
SC 13D | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000929638-99-000230 ( Act) Size: 47 KB |
Jun-14-1999 | 99645833 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-99-002031 ( Act) Size: 112 KB |
May-06-1999 | 99612115 |
10-K405/A | Document | Acc-no: 0000891618-99-001926 ( Act) Size: 58 KB | Apr-30-1999 | 99606232 |
10-K405 | Document | Acc-no: 0000891618-99-001268 ( Act) Size: 207 KB | Mar-31-1999 | 99579614 |
SC 13G | Document | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000891618-99-000656 ( Act) Size: 26 KB |
Feb-16-1999 | 99542839 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000799005-99-000017 ( Act) Size: 6 KB |
Feb-11-1999 | 99532328 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-98-004914 ( Act) Size: 193 KB |
Nov-13-1998 | 98748078 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-98-003842 ( Act) Size: 95 KB |
Aug-13-1998 | 98685669 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000891618-98-002436 ( Act) Size: 145 KB |
May-15-1998 | 98622225 |
DEF 14A | Document | Definitive proxy statements Acc-no: 0000891618-98-002055 ( Act) Size: 56 KB |
Apr-30-1998 | 98606878 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000891618-98-002054 ( Act) Size: 13 KB |
Apr-30-1998 | 98606726 |
10-K405 | Document | Acc-no: 0000891618-98-001431 ( Act) Size: 260 KB | Mar-31-1998 | 98580468 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001047469-98-006282 ( Act) Size: 9 KB |
Feb-17-1998 | 98540571 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000891618-98-000743 ( Act) Size: 10 KB |
Feb-17-1998 | 98540555 |
Recent 20 filings. View all UROQUEST MEDICAL CORP filings
Thanks I look forward to using the product to improve my skin tone
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by